s6y
Company name or ticker
Search
Bassler Bonnie L
4
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, February 7, 2023
Period
Feb 3, 2023
Accession number
0001883850-23-000036
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header